$74.00 $1.23 per serving
Product analysis
NiaCel 400 offers a simple combination of a niacin-related ingredient and betaine at a favorable serving cost. Unclear identification of the niacin form makes it harder to match the formula to a specific intended benefit.
AI assessment of the formula, label and price. How scoring works
Nutrient Quality30
The niacin form is not clearly identified on the label. Betaine is named, but its comparative quality cannot be established from the available information.
Ingredient Transparency81
Both ingredient amounts are disclosed. The betaine form is identified, while the niacin form remains unclear.
Value For Money100
The full serving cost compares favorably with both ingredients. The price comparison does not resolve the uncertainty over which niacin form is supplied.
Customer Satisfaction80
Customer ratings are largely positive. Feedback from many buyers provides a broad picture of satisfaction.
Product Focus30
The formula is simple, but its cardiovascular purpose remains uncertain. Conflicting niacin identification and an unresolved relevant amount prevent a clear link to that intended benefit.
- Format
Capsule - Container
- 60 Capsule(s)
- Per serving
- $1.23
- Customer rating
- 4.6 · 1,306 ratings
Goals
Impact
Situational effect
Niacin · 415 mg
Impact
Situational effect
Impact
Situational effect
Ingredients
| Ingredient | Amount per serving | Score |
|---|---|---|
Nicotinamide Riboside Hydrogen Malate | 415 mg | |
Betaine Anhydrous (Trimethylglycine) | 85 mg |
Niacin · 415 mg OverallScore85
Each serving provides 415 mg of nicotinamide riboside hydrogen malate. The amount of niacin itself is unknown. The serving price is low for this form. It uses nicotinamide riboside hydrogen malate.
How this ingredient is rated
Active Ingredient Quality & Bioavailability71
It uses nicotinamide riboside hydrogen malate.
Niacin Form & Goal Alignment
Nicotinamide Riboside Hydrogen Malate is the stated form.
Precursor Source Quality
The stated source is nicotinamide riboside hydrogen malate.
Dose, Safety & Label Transparency92
Each serving provides 415 mg of nicotinamide riboside hydrogen malate. The amount of niacin itself is unknown. No no-flush claim is recorded.
Clarity of Chemical Form
The form is disclosed as Nicotinamide Riboside Hydrogen Malate.
Form-Specific Dosage Efficacy
Each serving provides 415 mg of nicotinamide riboside hydrogen malate. The amount of niacin itself is unknown.
Flush Risk & Safety Labeling
No no-flush claim is recorded.
Value100
The serving price is low for this form.
Price Per Effective Serving
The serving price is low for this form.
Betaine Anhydrous (Trimethylglycine) · 85 mg OverallScore100
A serving provides 85 mg of betaine anhydrous at a moderate cost. The amount is clearly stated.
How this ingredient is rated
Active Ingredient Quality & Bioavailability100
The declared form is betaine anhydrous.
Betaine Form (Anhydrous/TMG vs. HCl)
The declared form is betaine anhydrous.
Dose, Safety & Label Transparency100
The selected serving lists 85 mg of betaine anhydrous.
Label Transparency & Blend Disclosure
The selected serving lists 85 mg of betaine anhydrous.
Value100
The cost per selected serving is moderate.
Price per Active Dose Efficiency
The cost per selected serving is moderate.
Alternative products
Report alternatives
Sources
Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.
- The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
- Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
- Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
- Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
- Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
- Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
- The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
- The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
- Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
- Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
- Niacinamide: A B vitamin that improves aging facial skin appearance.
- The clinical anti-aging effects of topical kinetin and niacinamide in Asians: a randomized, double-blind, placebo-controlled, split-face comparative trial.
- A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention.
- Nicotinamide for Skin Cancer Chemoprevention.